Aspen Pharmacare CEO Stephen Saad is in the C-SUITE on the manufacture of COVID-19 vaccine in SA.

Johnson and Johnson have agreed to the supply of 250 million vaccines for Africa with 30 million being for South Africa. Aspen Pharmacare will be manufacturing these vaccine’s at Aspen’s sterile facility in the Eastern cape.